A "universal" human influenza A vaccine

Virus Research

Volumn 103, Issue 1-2, 2004, Pages 173-176

  Fiers, W ^a   De Filette, M ^a   Birkett, A ^b   Neirynck, S ^a   Min Jou, W ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Apovia Inc   (United States)

Author keywords

Conserved sequence; Hepatitis B core; M2 protein; Universal influenza A vaccine

Indexed keywords

AMINO ACID; HEPATITIS B CORE ANTIGEN; INFLUENZA VACCINE; PROTEIN M2;

AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ANTIBODY TITER; CONFERENCE PAPER; EPIDEMIC; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CARRIER; VIRUS INFECTION; VIRUS ISOLATION;

AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; HEPATITIS B CORE ANTIGENS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; VIRAL MATRIX PROTEINS;

HEPATITIS B VIRUS; INFLUENZA VIRUS;

EID: 2442628108     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.02.030     Document Type: Conference Paper

References (12)

1. Anonymous, 2002. Draft WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics. WER (WHO) 77, 394-404.
2. Birkett A., Lyons K., Schmidt A., Boyd D., Oliveira G.A., Siddique A., Nussenzweig R., Calvo-Calle J.M., Nardin E.A. Modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect. Immun. 70:2002;6860-6870
3. Black R.A., Rota P.A., Gorodkova N., Klenk H.D., Kendal A.P. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J. Gen. Virol. 74:1993;143-146
4. Gregory V., Lim W., Cameron K., Bennett M., Marozin S., Klimov A., Hall H., Cox N., Hay A., Lin Y.P. Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J. Gen. Virol. 82:2001;1397-1406
5. Holsinger L.J., Lamb R.A. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology. 183:1991;32-43
6. Jameson J., Cruz J., Ennis F.A. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72:1998;8682-8689
7. Lamb R.A., Zebedee S.L., Richardson C.D. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 40:1985;627-633
8. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Min Jou W., Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5:1999;1119-1120
9. Pinto L.H., Holsinger L.J., Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell. 69:1992;517-528
10. Pumpens P., Grens E. Hepatitis B core particles as a universal display model: a structure-function basis for development. FEBS Lett. 442:1999;1-6
11. Reid A.H., Fanning T.G., Janczewski T.A., McCall S., Taubenberger J.K. Characterization of the 1918 "Spanis" influenza virus matrix gene segment. J. Virol. 76:2002;10717-10723
12. Wynne S.A., Crowther R.A., Leslie A.G. The crystal structure of the human hepatitis B virus capsid. Mol. Cell. 3:1999;771-780